The stock of Novogen Limited (ADR) (NASDAQ:NVGN) closed at 3.36 gaining 6.20% in yesterday’s trading session. Over the years, the top provider has been offering genomic services and solutions. Today it has made the much awaited announcement. It has disclosed that it will be collaborating with Pacific Biosciences of California (NASDAQ:PACB).The two will set out in a joint move to develop and promote novel applications. These will of course be based on the PacBio® Sequel® System.
According to some top trusted sources, the new applications that they will be coming up with under this particular consensus will be for a common course. The two will be focusing on both the translational and the basic research in the field of precision medicine. They will concentrate on sample processing, automation, workflow, database construction and algorithm development.
Real-Time (SMRT®) technology is associated with a uniform coverage and that is of course across the various genome regions, including low-diversity and palindromes regions of the genome.
Experts affirm that the Genome sequencing with PacBio Systems plays a major role in the delivery of more accurate and complete views of all of all forms of genomic variation. It is thus possible to observe SNPs/SNVs, mobile elements, structural variants, haplotypes, epigenetics, and variants in low-complexity regions.
The same experts move further to reveal that the Sequel System together with the isoform sequencing (Iso-Seq®) method help generate full-length cDNA sequences. These are later used in the profiling of the full complexity of the human transcriptome. Technological advancements are moving the world pretty fast. Some time back, it would have been impossible to discover novel genes, gene fusion events and isoforms.
Novogene according to some trusted sources has the capacity to run up to 10 PacBio Sequel Systems. Over the years it has based its operations in an enormous facility for SMRT Sequencing in a single location.
One of the company’s top officials while recently addressing a number of news reports opined, “Novogene has extensive expertise in developing and marketing high-quality end-to-end service solutions, from sample preparation to data analysis.”
